Baiyun Mountain (00874): Tianxin Pharmaceutical obtained Citicoline Sodium Injection (2ml: 0.25g, 4ml: 0.5g) “Drug Supplement Application Approval Notice”

Zhitong Finance App News, Baiyunshan (00874) announced that recently, Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. (hereinafter referred to as “Tianxin Pharmaceutical”), the holding subsidiary of the company, received the “Drug Supplement Application Approval Notice” for citin choline sodium injections (2ml: 0.25g, 4ml: 0.5g) approved and issued by the State Drug Administration.

Tianxin Pharmaceutical has now obtained the “Drug Supplement Application Approval Notice” for citin choline sodium injections (2ml: 0.25g, 4ml: 0.5g), increased the specifications of the drug and passed a consistent evaluation of the quality and efficacy of generic drugs, which is conducive to enhancing the market competitiveness of this product.